261
Participants
Start Date
March 26, 2019
Primary Completion Date
March 21, 2025
Study Completion Date
March 21, 2025
BMS-986165
Specified dose on specified days
Local Institution - 0108, Barranquilla
Local Institution - 0137, Taipei
Local Institution - 0100, CABA
Clinica Adventista Belgrano, Ciudad Autonoma de Buenos Aires
Local Institution - 0098, Rosario
Local Institution - 0039, Debrecen
Local Institution - 0095, Mendoza
Local Institution - 0038, Gyula
Local Institution - 0045, Szeged
Local Institution - 0051, Taipei
Local Institution - 0131, New York
Local Institution, Taipei
Local Institution - 0123, Brooklyn
Local Institution - 0053, Suwon
Local Institution - 0035, Wyomissing
Local Institution - 0031, Charlotte
Local Institution - 0126, Málaga
Local Institution - 0121, Charleston
Local Institution - 0050, Lawrenceville
Local Institution - 0094, Atlanta
Local Institution - 0140, Gainesville
Local Institution - 0133, Orlando
Local Institution - 0115, Aventura
Local Institution - 0044, Brandon
Local Institution - 0048, Tampa
Local Institution - 0080, León
Local Institution - 0086, León
Local Institution - 0001, Jackson
Local Institution - 0052, Taichung
Local Institution - 0124, Seville
Investigacion Biomedica para el Desarrollo de Farmacos S.A. de C.V., Zapopan
Local Institution - 0084, Monterrey
Local Institution - 0064, Oklahoma City
Local Institution - 0046, Mesquite
Local Institution - 0114, Dallas
Local Institution - 0037, Houston
Local Institution - 0082, San Luis Potosí City
Tekton Research - Austin, Austin
Local Institution - 0049, Torrance
Local Institution - 0030, El Cajon
Local Institution - 0101, Bogotá
Local Institution - 0068, Yaroslavl
Local Institution - 0060, Yaroslavl
Local Institution - 0062, Saint Petersburg
Local Institution - 0058, Saint Petersburg
Local Institution - 0070, Smolensk
Local Institution - 0002, Râmnicu Vâlcea
Local Institution - 0103, Chía
Local Institution - 0096, Zipaquirá
Local Institution - 0057, Orenburg
Local Institution - 0033, Brasov
Local Institution - 0055, Vladimir
Local Institution - 0061, Yekaterinburg
Local Institution - 0072, Novosibirsk
Local Institution - 0056, Kemerovo
Local Institution - 0004, Galati
Local Institution - 0063, Sendai
Local Institution - 0077, Birmingham
Local Institution - 0074, New Haven
Local Institution - 0032, Ormond Beach
Local Institution - 0071, Chapel Hill
Local Institution - 0041, Austin
Local Institution - 0125, Ciudad Autonoma de Buenos Aires
Local Institution - 0091, San Miguel de Tucum
Local Institution - 0122, Córdoba
Local Institution - 0116, Salvador
Local Institution - 0118, Goiߡ
Local Institution - 0106, Juiz de Fora
Local Institution - 0120, Curitiba
Local Institution - 0107, Porto Alegre
Local Institution - 0111, São Bernardo do Campo
Local Institution - 0105, São Paulo
University of Calgary, Calgary
Local Institution - 0136, Toronto
National Hospital Organization Chibahigashi National Hospital, Chiba
Local Institution - 0092, Kitakyushu
Local Institution - 0119, Sapporo
Hokkaido University Hospital, Sapporo
Local Institution - 0069, Shimotsuke
Local Institution - 0065, Chuo-ku
Local Institution - 0078, Tokyo
Local Institution - 0066, Tokyo
Local Institution - 0093, Tokyo
Local Institution - 0087, Mexico City
Local Institution - 0025, Bydgoszcz
Local Institution - 0015, Kościan
Local Institution - 0014, Krakow
Local Institution - 0027, Krakow
Local Institution - 0018, Krakow
Local Institution - 0016, Lublin
Local Institution - 0024, Poznan
Local Institution - 0029, Sosnowiec
Local Institution - 0019, Warsaw
Local Institution - 0022, Warsaw
Local Institution - 0010, Wroclaw
Local Institution - 0023, Wroclaw
Local Institution, Seoul
Local Institution - 0138, Sabadell
Lead Sponsor
Bristol-Myers Squibb
INDUSTRY